While ALK inhibitor treatment led to a reduction in phosphorylated AKT and the mTOR downstream target S6K1, AKT signaling was effectively reinduced following the cultivation of H2228 and H3122 tumor spheroids with CAF-CM (Fig. 7A, Additional File 3). Here, RPS6KB1 is linked to neoplasm.